By David Tuller, DrPH Update: The post indicates that more than 17,000 people had submitted the DecodeME questionnaire. Actually, as of the most recent count this month, DecodeME has now received more than 23,000 questionnaires. DecodeME paper finds ME/CFS severity linked to being female, being older and being sick longer DecodeME is a high-profile genome-wide …
By David Tuller, DrPH The Journal of Neurology, Neurosurgery, and Psychiatry (JNNP) has finally published a cogent rapid response to its recent whine de coeur from the PACE authors and their cronies. In the commentary, the co-authors criticized eight purported “anomalies” they believe occurred during the process of developing the 2021 ME/CFS guideline from Britain’s …
By David Tuller, DrPH I recently wrote about a Dutch study published a few months ago in the journal Clinical Infectious Diseases–“Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial.” The study, nick-named ReCOVer, found that unblinded trials relying on subjective outcomes will produce modestly positive reports …
By David Tuller, DrPH On July 10th, the Journal of Neurology, Neurosurgery, and Psychiatry (JNNP) published what can only be called a whine de coeur from a bunch of academics and investigators on the wrong side of a dispute with Britain’s National Institute for Health and Care Excellence (NICE). Their article was called “Anomalies in …
By David Tuller, DrPH UPDATE: Not long after I sent the letter repeating our request for a correction, I received a response directly from Professor Murray, the editor-in-chief of Psychological Medicine who had commented on the length of our initial request for a correction. Here it is: From: Robin Murray Date: Thu, Jul 20, 2023 at 9:02 AMSubject: …
By David Tuller, DrPH Two months ago, Clinical Infectious Diseases (CID), a high-impact journal, published a study called “Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial.” The study, nicknamed ReCOVer amd conducted in the Netherlands, purported to provide the “first evidence for the positive effect of …
